This Stock Holds The Key The Auto Industry Has Been Looking For
Lpath: Things Looking Brighter for Bioactive Lipid-Targeted Therapeutics Leader
Trading The Market's Top Triglyceride Challengers
Upcoming Dividend Leak Spurs More Buying For Neptune
Technical and Fundamental Reasons Why Neptune (NEPT) Should Be In Your Portfolio
Insider Buy at NVAX Spurs Some Speculation
Why Ampio's Rebound Run May Not Be Done
Corcept Therapeutics: One and Done or More to Come?
Trovagene: Built on Experience and Ready to Move Higher
Thinly Traded BioLineRx Shares Move on Hepatitis C Deal
Two Biotechs That Continue to Attract Positive Attention From Investors
The Drama Continues: Cell Therapeutics
Biotech Traders Have Astex Pharmaceuticals in their Sights
Achillion's Hep C Pipeline Likely Can't Compete
On the move: Shares of PROLOR Biotech Inc.
San Francisco Health Care Conferences Provide Plenty of Buzz and Chatter
Merck Hands Exelixis $12 Million Up Front For a Preclinical Compound Program
Key Phase IIb Clinical Trial Results Await Smoking Cessation Player This Week
Ampio Says Factually Inaccurate and Purposely Misleading Information Panicked Market
Threshold Pharmaceuticals Making Good Clinical Progress on Several Fronts